Perrigo Company plc (PRGO)
NYSE: PRGO · Real-Time Price · USD
24.74
-0.07 (-0.28%)
Apr 23, 2025, 4:00 PM EDT - Market closed
Perrigo Company Revenue
In the year 2024, Perrigo Company had annual revenue of $4.37B, down -6.06%. Perrigo Company had revenue of $1.14B in the quarter ending December 31, 2024, a decrease of -1.61%.
Revenue (ttm)
$4.37B
Revenue Growth
-6.06%
P/S Ratio
0.78
Revenue / Employee
$521,948
Employees
8,379
Market Cap
3.38B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 4.37B | -282.20M | -6.06% |
| Dec 31, 2023 | 4.66B | 204.00M | 4.58% |
| Dec 31, 2022 | 4.45B | 312.90M | 7.56% |
| Dec 31, 2021 | 4.14B | 50.50M | 1.24% |
| Dec 31, 2020 | 4.09B | 218.30M | 5.64% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 410.06B |
| Johnson & Johnson | 89.33B |
| Merck & Co. | 64.17B |
| AbbVie | 56.33B |
| AstraZeneca | 54.07B |
| Novartis AG | 51.72B |
| Eli Lilly and Company | 45.04B |
| Thermo Fisher Scientific | 42.88B |
PRGO News
- 13 hours ago - Perrigo to Release First Quarter 2025 Financial Results on May 7, 2025 - PRNewsWire
- 2 days ago - Trump Tariffs Could Have 'Significant Impact' On Perrigo Earnings, Says JP Morgan - Benzinga
- 14 days ago - Trump's Tariffs Circle Pharma Industry: Who It Affects And How It May Play Out - Seeking Alpha
- 7 weeks ago - Perrigo Company plc (PRGO) 2025 Investor Day (Transcript) - Seeking Alpha
- 7 weeks ago - Perrigo Provides Detailed Plan to Consumerize, Simplify and Scale its Unique Global Self-Care Platform at its Virtual Investor Day - PRNewsWire
- 7 weeks ago - 31 Upcoming Dividend Increases, Including 3 Kings - Seeking Alpha
- 7 weeks ago - Perrigo Reports Fourth Quarter & Fiscal Year 2024 Financial Results From Continuing Operations - PRNewsWire
- 2 months ago - Perrigo to Attend the UBS 2025 Global Consumer and Retail Conference - PRNewsWire